Featured insights
Nexyra guides you in knowledge
Insights from the Frontier of Biotech and Data Science
Stay ahead of the curve with curated articles, scientific deep dives, and expert commentary on the latest breakthroughs in multi-omics, bioinformatics, AI in biomedicine, and data-driven healthcare. This is where innovation meets interpretation — and where we turn complexity into clarity. Updated regularly by Nexyra’s science team and trusted external voices.
This article explores how integrating multiple omics layers — such as genomics, transcriptomics, proteomics, and metabolomics — enables a deeper, systems-level understanding of biology. It explains that multi-omics analysis allows researchers to identify novel biomarkers, improve patient stratification, and accelerate precision medicine. The piece also highlights Nexyra’s role in automating, standardizing, and interpreting omics data through advanced platforms and tailored reporting.
This article explores how the Omics-as-a-Service (OAS) model is transforming translational medicine by offering an end-to-end solution — from sample logistics and lab coordination to automated data analysis and tailored reporting. By reducing complexity, cost, and turnaround time, OaaS enables faster, more scalable research in clinical and biomedical environments.
Bio-digital convergence is revolutionizing medicine through the integration of omics sciences, artificial intelligence, quantum computing, and digital twins. These technologies enable progress toward more predictive, personalized, and efficient medicine. This article presents the 10 key DeepTech trends that are transforming biotechnology. Nexyra reaffirms its commitment to R&D innovation to implement these solutions in its portfolio. The biology of the future will be computational, ethical, and connected.
Most omics projects fail not because of poor data, but because they lack a clear connection to clinical or business outcomes. Governance is often treated as technical hygiene, rather than a strategic enabler. At Nexyra, we rethink omics governance to drive diagnostic precision, regulatory readiness, and commercial impact. Discover how outcome-oriented governance transforms data into real-world value.
From Raw Data to Insight: How Nexyra Turns Complexity into Clarity>
A high-level look at Nexyra’s unique approach to biomedical data: transforming large, heterogeneous datasets into actionable clinical and scientific insight. The article showcases our capabilities in multi-omics integration, report personalization, and decision support — delivering clarity from the moment a sample enters the pipeline.
White paper
How can the integration of multi-omics data, artificial intelligence, and digital twins transform treatment development for more than 300 million people with rare diseases?